These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7891885)
1. Individual metabolic anatomy of repeating words demonstrated by MRI-guided positron emission tomography. Herholz K; Pietrzyk U; Karbe H; Würker M; Wienhard K; Heiss WD Neurosci Lett; 1994 Nov; 182(1):47-50. PubMed ID: 7891885 [TBL] [Abstract][Full Text] [Related]
2. Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects. Hommer D; Andreasen P; Rio D; Williams W; Ruttimann U; Momenan R; Zametkin A; Rawlings R; Linnoila M J Neurosci; 1997 Apr; 17(8):2796-806. PubMed ID: 9092601 [TBL] [Abstract][Full Text] [Related]
3. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy]. Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328 [TBL] [Abstract][Full Text] [Related]
4. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma. Benyounes H; Smith FW; Campbell C; Evans NT; Norton MY; Mikecz P; Heys SD; Bruce D; Eremin O; Sharp PF Nucl Med Commun; 1995 Jul; 16(7):575-80. PubMed ID: 7478396 [TBL] [Abstract][Full Text] [Related]
5. The Marinesco-Sjögren syndrome examined by computed tomography, magnetic resonance, and 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography. Bromberg MB; Junck L; Gebarski SS; McLean MJ; Gilman S Arch Neurol; 1990 Nov; 47(11):1239-42. PubMed ID: 2241622 [TBL] [Abstract][Full Text] [Related]
6. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects. Maquet P; Dive D; Salmon E; von Frenckel R; Franck G Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175 [TBL] [Abstract][Full Text] [Related]
7. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929 [TBL] [Abstract][Full Text] [Related]
8. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study. Kinnala A; Suhonen-Polvi H; Aärimaa T; Kero P; Korvenranta H; Ruotsalainen U; Bergman J; Haaparanta M; Solin O; Nuutila P; Wegelius U Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F153-7. PubMed ID: 8777676 [TBL] [Abstract][Full Text] [Related]
9. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle. Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586 [TBL] [Abstract][Full Text] [Related]
10. Temporoparietal cortex in aphasia. Evidence from positron emission tomography. Metter EJ; Hanson WR; Jackson CA; Kempler D; van Lancker D; Mazziotta JC; Phelps ME Arch Neurol; 1990 Nov; 47(11):1235-8. PubMed ID: 2241621 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in diagnosing brainstem vascular lesions that cause abnormal eye movements. Kiyosawa M; Ishii K; Inoue C; Kawasaki T; Senda M Am J Ophthalmol; 1996 Oct; 122(4):557-67. PubMed ID: 8862054 [TBL] [Abstract][Full Text] [Related]
12. Metabolic disturbances in exo-focal brain areas after cortical stroke studied by positron emission tomography. Nagasawa H; Kogure K; Fujiwara T; Itoh M; Ido T J Neurol Sci; 1994 May; 123(1-2):147-53. PubMed ID: 8064308 [TBL] [Abstract][Full Text] [Related]
13. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. Choi Y; Hawkins RA; Huang SC; Gambhir SS; Brunken RC; Phelps ME; Schelbert HR J Nucl Med; 1991 Apr; 32(4):733-8. PubMed ID: 2013815 [TBL] [Abstract][Full Text] [Related]
16. Regional glucose metabolic rates in the human brain: a PET study. Gulyás B; Trón L; Balkay L; Emri M; Molnár T; Tóth G; Marian T Acta Biol Hung; 1996; 47(1-4):157-72. PubMed ID: 9123988 [TBL] [Abstract][Full Text] [Related]
17. PET studies of cerebral glucose metabolism in conscious rhesus macaques. Eberling JL; Roberts JA; De Manincor DJ; Brennan KM; Hanrahan SM; Vanbrocklin HF; Roos MS; Jagust WJ Neurobiol Aging; 1995; 16(5):825-32. PubMed ID: 8532117 [TBL] [Abstract][Full Text] [Related]
18. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Otte A; Weiner SM; Peter HH; Mueller-Brand J; Goetze M; Moser E; Gutfleisch J; Hoegerle S; Juengling FD; Nitzsche EU Eur J Nucl Med; 1997 Jul; 24(7):787-91. PubMed ID: 9211766 [TBL] [Abstract][Full Text] [Related]
19. Hemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose. Dubinsky RM; Greenberg M; Di Chiro G; Baker M; Hallett M Mov Disord; 1989; 4(4):310-9. PubMed ID: 2811890 [TBL] [Abstract][Full Text] [Related]
20. [Cerebral glucose metabolism in dementia (PET-FDG study)]. Hatazawa J; Itoh M; Matsuzawa T Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]